I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Papillary fibroelastoma is a rare benign cardiac tumor (7%--9% of benign primary tumors\[[@ref1]\]), second after cardiac myxoma as more frequent cardiac valvular tumor.\[[@ref2]\] In 85% of cases, it is a valvular disease affecting aortic valve (35%--63%), mitral valve (9%--35%), tricuspid valve (6%--15%), and pulmonary valve (0.5%--8%)\[[@ref3]\] and in a very few cases nonvalvular sites, with left ventricular masses documented on the septum\[[@ref4][@ref5]\] and the outflow tract.\[[@ref6][@ref7]\] Fibroelastomas have also been reported on the right ventricular papillary muscles.\[[@ref1]\] The atrial side of the mitral valve is more often affected by the disease;\[[@ref8]\] and dimensions may vary from 2 to 70 mm.

Fibroelastomas appear as "sea anemones," after the multiple frond-like projections, especially in saline solution after surgical resection, they are considered as hamartomas with endothelial origin secondary to turbulent high-stress flow and endothelial dysfunction with proliferation. Iatrogenic cardiac trauma and virus-induced tumor genesis have been also proposed. The majority (75%) of fibroelastomas arise from the valvular endothelium and are left sided.\[[@ref9]\] Histology shows endothelium surrounding a layer of mucopolysaccharides and an inner vascular core of connective tissue. The amount of collagen, smooth muscle cells, and elastic fibers is variable within the connective tissue matrix. While fibroelastomas growth is very slow, the risk of superficial thrombosis and embolization is significant.\[[@ref10][@ref11]\] Therefore, even though the majority of cases are asymptomatic, cases of myocardial infarction, stroke, pulmonary embolism, retinal artery embolism, heart failure, and ventricular fibrillation have been also reported. Right-sided fibroelastomas are an important and potentially fatal cause of sudden cardiac death, syncope, chest pain, and dyspnea.\[[@ref9]\]

The therapy is usually based on the surgery according to size, mobility, symptoms, and risks of surgery.

C[ASE]{.smallcaps} R[EPORT]{.smallcaps} {#sec1-2}
=======================================

A 67-year old female came to our attention after a recent transient ischemic attack. Echocardiography showed the presence of a round mobile formation of 12 mm × 9 mm localized on the atrial side of septal leaflets of tricuspid valve \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\], first identified as an endocarditis vegetation. Cardiac magnetic resonance (cMRI) confirmed the presence of the mass and showed an isointense signal in T1-turbo spin echo sequences \[[Figure 1c](#F1){ref-type="fig"}\], hypointense in cine steady-state free precession and in first-pass sequences \[[Figure 1d](#F1){ref-type="fig"}\], and hyperintense in T2 and phase-sensitive inversion recovery with central hypointense core \[Figure [1e](#F1){ref-type="fig"} and [f](#F1){ref-type="fig"}\], with a suspected diagnosis of fibroelastoma.

![(a and b) echocardiography showing a 12 mm × 9 mm formation localized on the atrial side of tricuspid valve septal leaflets. Cardiac magnetic resonance confirmed the presence of the mass and showed an isointense signal in T1-turbo spin echo sequences (c), hypointense in cine steady-state free precession and in first-pass sequences (d), and hyperintense in T2 and phase-sensitive inversion recovery with central hypointense core (e and f), with a suspected diagnosis of fibroelastoma](JCE-28-236-g001){#F1}

The patient underwent cardiac surgery that showed the presence of polypoid cardiac mass (15 mm × 10 mm × 10 mm) with a large base of 10 mm localized on the atrial side of septal leaflets of tricuspid valve \[Figure [2a](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"}\]. Histology confirmed the presence of fibroelastic tissue with papillary extroflexions compatible with diagnosis of fibroelastoma.

![(a-c) polypoid cardiac mass (15 mm × 10 mm × 10 mm) with a large base of 10 mm localized on the atrial side of septal leaflets of the tricuspid valve](JCE-28-236-g002){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Papillary fibroelastoma is a rare, more often incidentally found, form of benign cardiac tumor, usually affecting left cardiac valves. Its early diagnosis is paramount to avoid complications such as pulmonary or paradox embolism into systemic circulation. Diagnostic workup to exclude myxomas and valvular endocarditis must be careful. Clinical history, characteristic, size, and position are generally useful for differential diagnosis; echocardiography usually shows a small, mobile, pedunculated, or sessile valvular or endocardial mass, which on many occasions flutters or prolapses into the cardiac chambers during systole or diastole. Echodensity of the tumor\'s central collagen core strongly supports the diagnosis and allows the distinction from other intracardiac tumors, vegetations, or mural thrombi.\[[@ref11]\] Furthermore, cardiac computed tomography (CT) may be useful for the diagnosis of papillary fibroelastomas, with excellent spatial resolution; however, shortcomings as contrast medium and radiation exposure remain.\[[@ref12]\] The principal limitation of CT is the lack of soft-tissue contrast resolution. For these reasons, cardiac MRI may presently represent the gold standard for preoperative diagnosis of such cardiac mass. cMRI assessment with gadolinium can be used to distinguish thrombi from tumor after the lack of enhancement.\[[@ref13]\] Furthermore, cMRI provides an unrestricted spatial approach, high temporal resolution (30--50 ms), and noninvasive tissue characterization based on multiparametric assessment of the chemical microenvironment, thus allowing noninvasive tissue characterization. cMRI, however, may have limitations with small (\<10 mm) and highly mobile masses, as fibroelastomas often are.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

The use of cMRI may be useful in the evaluation of exact position, dimensions, and nature of cardiac masses and fibroelastomas, diagnostic workup, and preliminary assessment before the surgery.
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